Purchase Order 75N95022P00647
- Not listed
- The National Institute on Drug Abuse awarded a $67,270 purchase order to Certara USA Inc. on September 22, 2025, for small molecules and biologics toxicology consultant support services. The contract, which will be performed in Wayne, Pennsylvania, extends through September 21, 2028, and utilizes a labor hours pricing model with no set-aside designation. Certara USA Inc. is a leading drug development and drug safety consultancy specializing in biosimulation software and expert consulting...
- The National Institute of Neurological Disorders and Stroke (NINDS), under the National Institute on Drug Abuse (NIDA), awarded a $2.37M purchase order contract to Toxstrategies, LLC on September 20, 2022, for toxicology consulting services supporting the NIH Blueprint Neurotherapeutics Network (BPN), the Helping to End Addiction Long-term (HEAL) Initiative, and other NIH neuroscience-focused drug discovery and development programs. The contract, which carries no small business set-aside...
- This federal contract award provides small molecules and biologics toxicology consultant support services to the National Institute on Drug Abuse (NIDA), a civilian agency. The $28,000.00 purchase order contract was awarded to Toxstrategies, LLC, a for-profit small business, on September 22, 2025 with a completion date of September 21, 2028. The work is to be performed in Katy, Texas. The original solicitation was a pre-solicitation notice from the National Institute of Neurological Disorders...
- The National Institutes of Health, National Institute of Neurological Disorders and Stroke awarded a $591,600 labor-hour contract to Toxstrategies, LLC to provide toxicology consulting services in support of the Helping to End Addiction Long-term Initiative and other neuroscience drug discovery programs. The contract is set aside for small businesses. Toxstrategies will provide a minimum of 20 hours annually of consulting services on Lead Development Teams, including evaluating chemical...
- This $11,660 firm fixed-price purchase order contract was awarded to Certara USA Inc. by the National Institutes of Health (NIH) Clinical Center, a civilian agency. The contract is for the procurement of software licenses and subscriptions for Certara's proprietary modeling and simulation tools, which enable federal scientists and reviewers to conduct clinical pharmacology, pharmacometric, and regulatory review analyses on data submitted by industry sponsors. Certara USA Inc. is a leading global...
- The federal contract award, valued at $10,743.00, was issued by the National Cancer Institute (NCI) to Certara USA Inc., a leading global technology-enabled drug development and drug safety consultancy, for the procurement of software licenses. The contract is a firm-fixed price purchase order with no set-aside designation and an ultimate completion date of August 13, 2025. Certara USA Inc. has received numerous prime contract awards from the NCI, Food and Drug Administration (FDA), and National...
- This purchase order award from the Department of Health and Human Services' National Institutes of Health's National Institute of Neurological Disorders and Stroke to Detke Biopharma Consulting LLC is for $70,500 to provide pharmacology consulting services in support of the NIH Blueprint Neurotherapeutics Network (BPN) drug discovery and development programs through February 2025. As a member of the BPN External Oversight Committee, the contractor will provide strategic guidance and technical...
- The National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services, awarded a $9,000.00 Purchase Order contract for Medicinal Chemistry Consulting Services to Nigel J Liverton, a small business located in San Antonio, Texas. The contract, which runs through September 28, 2026, is to provide technical guidance and recommendations to support the NIH Blueprint Neurotherapeutics Network drug discovery and development programs, as well as other NIH...
- This is a $443,240.75 labor-hour purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Integrated Nonclinical Development Solutions Inc. (IND Solutions), a small business subchapter S corporation, to provide toxicology consultant support services for the NIH Blueprint Neurotherapeutics Network (BPN) drug discovery and development programs. The contract is a 100% small business set-aside and...
- The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $70,500 purchase order to Darryle Schoepp of Schoepp, Darryle for pharmacology consulting services in support of the NIH Blueprint Neurotherapeutics Network (BPN) drug discovery and development programs and associated BPN External Oversight Committee. The solicitation sought a highly experienced executive-level drug discovery and development subject matter...
This federal contract award to Certara USA Inc. is for toxicology consulting services to support the National Institute of Neurological Disorders and Stroke (NINDS), the National Institutes of Health (NIH) Blueprint Neurotherapeutics Network (BPN), the NIH Helping to End Addiction Long-term (HEAL) Initiative, and other NIH neuroscience-focused drug discovery and development programs. The $2,167,500.00 purchase order contract has a completion date of September 19, 2025 and is not a set-aside award. Certara, a leading global technology-enabled drug development and drug safety consultancy, will provide senior scientific expertise in toxicology to guide these NIH neuroscience initiatives. This contract award aligns with Certara's history of providing specialized software, subscriptions, and consulting services to federal health agencies like the FDA, NIH, and NCI.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Toxicology Consulting Services | 75N95022R00076 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 1/3 | 8/4/22, 4:54 PM | |
Toxicology Consulting Services | 75N95022R00076 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Award Notice 2/3 | 10/5/22, 12:55 PM | |
Toxicology Consulting Services | 75N95022R00076 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Award Notice 3/3 | 10/5/22, 1:04 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Exercise an Option | $45.0k | 1/22/25 | |
| P00003 | Exercise an Option | $160.2k | 8/21/24 | |
| P00002 | Exercise an Option | $1.5k | 9/26/23 | |
| P00001 | Exercise an Option | $42.0k | 8/16/23 | |
| Not listed | Not listed | $42.0k | 9/19/22 |